pentobarbital will lessen the level or effect of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not suggested; solid cytochrome P450 enzyme inducers minimize systemic exposure to roflumilast and will decrease the therapeutic usefulnessThe group gives information and facts packets for these Lo